51564-101 : Virazole .1 g/ml Intravenous Liquid

Labeler: Legacy Pharmaceuticals Switzerland Gmbh
Product Type: Human Prescription Drug
Drug Name:  Virazole
Dosage Form: Intravenous Liquid
Rev. Date: 

NDC Package Codes:

  • 51564-101-11: 12 ML IN 1 VIAL (51564‑101‑11)

Active Ingredients:

  • Ribavirin

Dosage Strength:

  • .1 g/mL

Pharmaceutical Classes:

  • Nucleoside Analog [Chemical/Ingredient]
  • Nucleoside Analog Antiviral [EPC]

Related Products:

Based on records with the same trade name.
  • 0187-0007 Virazole 6 g/1 Respiratory (Inhalation) Powder, for Solution by Valeant Pharmaceuticals North America LLC


Scan the QR code below to easily reference this data in the future:

NDC 51564-101 QR Code

< Prev: 51561-001Next: 51567-001 >

Related Discussions:

Ribavirin reaction
I took peginterferon shots once a week with 6 ribavirin tablets a day. I had skin reactions and scatched all the hair of... 3 replies
Ribavirin-Interferon long term side effects
Hi. I was treated for chronic Hep C 20 years ago and been having continuous health problems arise over past 5 years. I w... 1 reply
sovaldi and ribavirin
66 years old, geno 2, 24 mo treatment, just finished treatment jan.5, 2015, now feb 8, still have headaches, itching, an... 4 replies
drug interaction with sovaldi and ribavirin
can you take lithium while taking sovaldi and ribavirin ## Hello, Polly! How are you? I didn't find any interactions... 2 replies
Dear sir; requesting your kind assistance to provide me with the AMERICAN EQUIVALENT DRUG NUMBER (AE) of:- 1- Pegasys in...

Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 20 January 2018.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA